摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

吡啶并[3,2-g]喹啉 | 260-67-3

中文名称
吡啶并[3,2-g]喹啉
中文别名
——
英文名称
Pyrido<3,2-g>quinoline
英文别名
pyrido[3,2-g]quinoline;Pyrido[3,2-g]chinolin;pyrido[3,2-g]quinoline;m-Phenanthrolin
吡啶并[3,2-g]喹啉化学式
CAS
260-67-3
化学式
C12H8N2
mdl
——
分子量
180.209
InChiKey
RFGXNUXNXWMFRQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    25.8
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:ab6a986d9c6e4223e46ee05d29b90b9d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    2,8-二甲基吡啶并[3,2-g]喹啉 2,8-dimethyl-pyrido[3,2-g]quinoline 89060-84-4 C14H12N2 208.263
    —— 2,8-bis-tribromomethyl-pyrido[3,2-g]quinoline 681463-56-9 C14H6Br6N2 681.639

反应信息

点击查看最新优质反应信息

文献信息

  • 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
    申请人:——
    公开号:US20030149268A1
    公开(公告)日:2003-08-07
    Non-steroidal compounds and compositions which are agonists, partial agonists, and antagonists for androgen receptors and methods of preparation for the non-steroidal compounds and compositions.
    非甾体化合物和组合物,它们是雄激素受体的激动剂、部分激动剂和拮抗剂,以及非甾体化合物和组合物的制备方法。
  • ORGANIC COMPOUND, THREE-DIMENSIONAL ORGANIC FRAMEWORK FORMED BY USING ORGANIC COMPOUND, SEPARATION SIEVE AND OPTICAL LAYER, WHICH COMPRISE ORGANIC FRAMEWORK, AND OPTICAL DEVICE COMPRISING OPTICAL LAYER AS OPTICAL AMPLIFICATION LAYER
    申请人:INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY
    公开号:US20190031586A1
    公开(公告)日:2019-01-31
    An organic compound, a three-dimensional organic structure formed by using the organic compound, a separation sieve and an optical layer having the organic structure, and an optical device having the optical layer as an optical amplification layer are provided. The organic structure includes a plurality of organic molecules self-assembled by non-covalent bonding. Each of the unit organic molecules has an aromatic ring, a first pair of substituents being connected to immediately adjacent positions of substitutable positions of the aromatic ring, and a second pair of substituents being connected to immediately adjacent positions of remaining substitutable positions of the aromatic ring. The unit organic molecules are self-assembled by van der Waals interaction, London dispersion interaction or hydrogen bonding between the first and the second pairs of the substituents and by pi-pi interactions between the aromatic rings.
    提供一种有机化合物,通过使用该有机化合物形成的三维有机结构、分离筛和具有该有机结构的光学层,以及具有光学层作为光学放大层的光学器件。该有机结构包括通过非共价键自组装的多个有机分子。每个单元有机分子具有芳香环,第一对取代基连接到芳香环的可取代位置的相邻位置,第二对取代基连接到芳香环的剩余可取代位置的相邻位置。单元有机分子通过范德华力相互作用、伦敦分散相互作用或氢键作用于第一和第二对取代基之间的π-π相互作用而自组装。
  • ORGANIC ELECTROLUMINESCENT DEVICE
    申请人:Merck Patent GmbH
    公开号:US20170077418A1
    公开(公告)日:2017-03-16
    The present invention relates to organic electroluminescent devices, the emitting layer thereof containing a blend of a luminescent material having a narrow singlet-triplet gap and a fluorescent emission material having high steric shielding.
    本发明涉及有机电致发光器件,其中发光层包含具有狭窄单重-三重能隙的发光材料和具有高立体屏蔽的荧光发射材料的混合物。
  • Organic photochromic compound, a dimer of pyrido quinoline
    申请人:Seikisui Kagaku Kogyo Kabushiki Kaisha
    公开号:US05091535A1
    公开(公告)日:1992-02-25
    An organic photochromic compound with improved long term preservability, thermal stability, the repetition character of the record and the like and useful as recording-memory materials or photosensitizers, comprising dimers of the compounds selected from the group consisting of pyrido[3,4-g]isoquinoline, pyrido[2,3-g]quinoline, pyrido[3,2-g]quinoline and pyrido[3,2-g]quinoline derivatives.
    一种具有改善的长期保存性、热稳定性、记录的重复性等特性的有机光致变色化合物,可用作记录记忆材料或光敏剂,包括从吡啶并[3,4-g]异喹啉、吡啶并[2,3-g]喹啉、吡啶并[3,2-g]喹啉和吡啶并[3,2-g]喹啉衍生物组成的化合物二聚体。
  • Steroid receptor modulator compounds and methods
    申请人:——
    公开号:US20040186132A1
    公开(公告)日:2004-09-23
    Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds, methods for employing the disclosed compounds and compositions for treating patients requiring steroid receptor agonist or antagonist therapy, intermediates useful in the preparation of the compounds and processes for the preparation of the steroid receptor modulator compounds.
    本文披露了高亲和力、高选择性的非类固醇化合物,可作为类固醇受体调节剂。同时也披露了包含这些化合物的药物组合物,以及使用这些化合物和组合物治疗需要类固醇受体激动剂或拮抗剂治疗的患者的方法,还包括制备这些化合物的中间体和制备类固醇受体调节剂化合物的方法。
查看更多